BAFF, His-Avi-Tag Recombinant
Recombinant human BAFF (B-cell-activating factor, also known as TNFSF13B, Tumor necrosis factor ligand superfamily member 13B), encompassing amino acids 134-285. This construct contains an N-terminal His-tag (6xHis) followed by an Avi-Tag™. The recombinant protein was affinity purified.
≥90%
8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol
B-cell activating factor (BAFF) is a cytokine regulating B cell development, survival, and antibody production. It is a key player in the immune response and has implications in autoimmune diseases. It is a ligand for receptors TNFRSF13B/TACI, TNFRSF17/BCMA, and TNFRSF13C/BAFFR. BAFF normally maintains immune balance, and overproduction of BAFF leads to various auto-immune diseases. It is, therefore, a therapeutic target. Drugs that inhibit BAFF, such as belimumab, have been approved for the treatment of certain autoimmune disorders.
1. Knight AK, et al. Clin. Immunol. 124 (2), 182-189 (2007)
2. Hever, A., et al. Proc. Natl. Acad. Sci. U.S.A. 104 (30), 12451-12456 (2007)